Pulse Biosciences Inc Quick Ratio (PLSE) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Pulse Biosciences Inc   (NASDAQ: PLSE)

Pulse Biosciences Inc 's Quick Ratio

PLSE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Pulse Biosciences Inc 's Cash & cash equivalent grew by 48.74 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Pulse Biosciences Inc 's Quick Ratio to 9.26, Quick Ratio remained below Pulse Biosciences Inc average.

Within Medical Equipment & Supplies industry 13 other companies have achieved higher Quick Ratio than Pulse Biosciences Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 461 to 500.

Explain Quick Ratio?
How much Cash & cash equivalents PLSE´s has?
What are PLSE´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PLSE Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 22.28 % 26.24 % -21.2 % 43.9 % 222.6 %
Y / Y Cash & cash equivalent Change -4.45 % -42.72 % -31.6 % 20.47 % 305.97 %
Quick Ratio MRQ 9.26 6.97 10.19 9.82 11.85
PLSE's Total Ranking # 500 # 461 # 229 # 246 # 226
Seq. Current Liabilities Change 12.07 % 23.64 % -18.32 % 8.04 % 15.7 %
Seq. Cash & cash equivalent Change 48.74 % -15.38 % -15.21 % -10.47 % -10.84 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 14
Healthcare Sector # 176
Overall Market # 500


Quick Ratio Statistics
High Average Low
35.1 11.41 2.88
(Jun 30 2016)   (Mar 31 2022)




Financial Statements
Pulse Biosciences Inc 's Current Liabilities $ 11 Millions Visit PLSE's Balance sheet
Pulse Biosciences Inc 's Cash & cash equivalent $ 102 Millions Visit PLSE's Balance sheet
Source of PLSE's Sales Visit PLSE's Sales by Geography


Cumulative Pulse Biosciences Inc 's Quick Ratio

PLSE's Quick Ratio for the trailling 12 Months

PLSE Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 14.5 % 33.13 % 53.45 % 91.61 % 127.63 %
Y / Y Cash & cash equivalent TTM Growth -18.17 % 2.36 % 55.56 % 137.9 % 171.25 %
Quick Ratio TTM 9.01 9.63 11.69 12.03 12.61
Total Ranking TTM # 3323 # 3365 # 2520 # 1992 # 2448
Seq. Current Liabilities TTM Growth 5.49 % 5.93 % -5.84 % 8.82 % 22.66 %
Seq. Cash & cash equivalent TTM Growth -1.35 % -12.69 % -8.5 % 3.83 % 23.4 %

Quick ratio ranking by company, industry and sector >> Back to PLSE Financial Strength Comparisons >> Go to Compare PLSE Quick Ratio to its Competitors

On the trailing twelve months basis Due to increase in Current Liabilities in the Q2 2026 to $10.98 millions, cumulative Quick Ratio decreased to 9.01 above the PLSE average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 189 other companies have achieved higher Quick Ratio than Pulse Biosciences Inc . While Quick Ratio overall ranking has improved so far to 3323, from total ranking during the twelve months ending first quarter 2026 at 3365.

Explain Quick Ratio?
How much Cash & cash equivalents PLSE´s has?
What are PLSE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 190
Healthcare Sector # 847
Within the Market # 3323


trailing twelve months Quick Ratio Statistics
High Average Low
12.61 6.42 2.2
(Jun 30 2025)   (Jun 30 2017)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Anteris Technologies Global Corp   14.02 $ 257.385  Millions$ 18.360  Millions
Heartflow Inc   13.95 $ 615.238  Millions$ 44.088  Millions
Ceribell Inc   13.13 $ 225.898  Millions$ 17.200  Millions
Perspective Therapeutics Inc   12.80 $ 467.708  Millions$ 36.544  Millions
Lemaitre Vascular Inc   12.57 $ 376.240  Millions$ 29.935  Millions
Mobia Medical Inc   12.24 $ 177.090  Millions$ 14.472  Millions
Envveno Medical Corporation  11.39 $ 21.486  Millions$ 1.887  Millions
Pulse Biosciences Inc   9.26 $ 101.620  Millions$ 10.978  Millions
Orchestra Biomed Holdings Inc   8.16 $ 109.963  Millions$ 13.471  Millions
Biolife Solutions Inc   8.11 $ 113.100  Millions$ 13.947  Millions
Bone Biologics Corporation  7.87 $ 4.032  Millions$ 0.512  Millions
Beyond Air Inc   7.68 $ 26.340  Millions$ 3.428  Millions
Talkspace Inc   7.62 $ 90.998  Millions$ 11.937  Millions
Safe Pro Group Inc   7.24 $ 10.231  Millions$ 1.413  Millions
Delcath Systems Inc   7.22 $ 95.902  Millions$ 13.279  Millions
Streamex Corp   7.16 $ 18.586  Millions$ 2.595  Millions
Endra Life Sciences Inc  7.04 $ 5.540  Millions$ 0.787  Millions
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions

Date modified: 2026-09-08T21:36:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.